12/07/2021
https://www.congress.gov...
"I would like to ask the other witnesses--Ms. Haycombe was asked about the potential effects of a $6 billion cut in NIH to medical innovation."
"I'd like to keep it that way, and I'm hopeful we can move beyond the failed Trumpcare proposal and work together to build on the progress we have made in our healthcare system."
"While drug pricing is outside of the FDA's jurisdiction and the most robust solutions likely involve HHS and CMS, this is something this committee needs to address this Congress."
"Do you share her view that a budget cut of that magnitude to the NIH would be devastating to medical innovation?"